CA2426589A1 - Reactifs et methodes diagnostiques a base de psp94 - Google Patents

Reactifs et methodes diagnostiques a base de psp94 Download PDF

Info

Publication number
CA2426589A1
CA2426589A1 CA002426589A CA2426589A CA2426589A1 CA 2426589 A1 CA2426589 A1 CA 2426589A1 CA 002426589 A CA002426589 A CA 002426589A CA 2426589 A CA2426589 A CA 2426589A CA 2426589 A1 CA2426589 A1 CA 2426589A1
Authority
CA
Canada
Prior art keywords
seq
psp94
polypeptide
pta
cell line
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002426589A
Other languages
English (en)
Inventor
Jonathan Reeves
Jerome Edward Tanner
Chandra J. Panchal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ambrilia Biopharma Inc
Original Assignee
Procyon Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2380662 external-priority patent/CA2380662A1/fr
Priority claimed from CA002391438A external-priority patent/CA2391438A1/fr
Application filed by Procyon Biopharma Inc filed Critical Procyon Biopharma Inc
Priority to CA002426589A priority Critical patent/CA2426589A1/fr
Publication of CA2426589A1 publication Critical patent/CA2426589A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002426589A 2002-05-01 2003-05-01 Reactifs et methodes diagnostiques a base de psp94 Abandoned CA2426589A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002426589A CA2426589A1 (fr) 2002-05-01 2003-05-01 Reactifs et methodes diagnostiques a base de psp94

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CA 2380662 CA2380662A1 (fr) 2002-05-01 2002-05-01 Reactifs et methodes diagnostiques a base de psp94
CA2,380,662 2002-05-01
CA002391438A CA2391438A1 (fr) 2002-05-01 2002-06-25 Reactifs et methodes diagnostiques a base de psp94
CA2,391,438 2002-06-25
CA002426589A CA2426589A1 (fr) 2002-05-01 2003-05-01 Reactifs et methodes diagnostiques a base de psp94

Publications (1)

Publication Number Publication Date
CA2426589A1 true CA2426589A1 (fr) 2003-11-01

Family

ID=29423911

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002426589A Abandoned CA2426589A1 (fr) 2002-05-01 2003-05-01 Reactifs et methodes diagnostiques a base de psp94

Country Status (1)

Country Link
CA (1) CA2426589A1 (fr)

Similar Documents

Publication Publication Date Title
CN1714150B (zh) 肿瘤内差异表达的基因产物及其应用
KR100512819B1 (ko) 종양 치료용 조성물 및 방법
US20220098290A1 (en) Antibodies that bind to cleaved form of mutant calreticulin, and diagnostic, preventive, or therapeutic agent for myeloproliferative neoplasm
EP1891108A1 (fr) Réactifs et dosages diagnostiques permettant de détecter la protéine psp94
JPH10501411A (ja) 細胞周期非依存性グリオーマ細胞表面抗原特異的ヒト・モノクロナール抗体
JPH06505011A (ja) ｅｒｂＢ−２受容体タンパク質に結合し且つ細胞性応答を誘導するリガンド成長因子
US20040009164A1 (en) PSP94 diagnostic reagents and assays
EP1187853B1 (fr) Nouvelles utilisations diagnostiques d'anticorps diriges contre l'acetylcholinesterase ou ses peptides c-terminaux
JP2726264B2 (ja) Ｎ‐ｍｙｃタンパク質のためのアッセイ及び抗体
KR20090014979A (ko) 신장암 진단 조성물 및 키트
US20040248257A1 (en) SPEX compositions and methods of use
CA2426589A1 (fr) Reactifs et methodes diagnostiques a base de psp94
JP4990459B2 (ja) 新規ヒトｕｌｉｐ／ｃｒｍｐタンパク質と癌及び傍新形成性神経症候群の診断及び治療におけるその使用
JPH06511151A (ja) アルコール中毒患者を同定しアルコール消費を監視するためのイムノアッセイ
CN113929778A (zh) 抗肌红蛋白的抗体以及试剂盒
CN110713544A (zh) 融合基因plekha6-ntrk3及其在lch中的应用
CN117327177B (zh) 抗脂联素抗体、检测脂联素的试剂和试剂盒
CN112920272B (zh) 抗cTnI的蛋白和检测cTnI的方法
CN112979816B (zh) 针对ckmb的结合蛋白及其应用
JPH10313876A (ja) 抗腫瘍タンパク質およびその遺伝子
JP3268147B2 (ja) モノクローナル抗体
CN117285639A (zh) 一种抗乙基葡萄糖醛酸苷抗体、检测乙基葡萄糖醛酸苷的试剂和试剂盒
CN117088975A (zh) 抗白蛋白抗体、检测白蛋白的试剂和试剂盒
CN117229408A (zh) 一种抗巴比妥类化合物抗体、检测巴比妥类药物的试剂和试剂盒
CN112979813A (zh) 一种可特异性结合检测人附睾蛋白4的结合蛋白及其制备方法和应用

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead